Dr. Alan Schroeder, MD
Claim this profileLucile Packard Children's Hospital Stanford
Studies Bronchiolitis
Studies Soft Tissue Infections
2 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Alan Schroeder, MD is currently running
Automatic vs. As-Needed Follow-Up
for Infections
Compare the effectiveness of automatic vs as-needed (PRN) post-hospitalization follow-up for children who are hospitalized for common infections.
Recruiting1 award N/A3 criteria
Educational and Feedback Interventions
for Bronchiolitis
The purpose of this study is to identify the optimal deimplementation strategies for an overused practice: continuous pulse oximetry monitoring of children hospitalized with bronchiolitis who are not receiving supplemental oxygen.
Recruiting1 award N/A14 criteria
More about Alan Schroeder, MD
Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Alan Schroeder, MD has experience with
- Audit & Feedback (real Time, Individual-level)
- Audit & Feedback (unit Level)
- Clinical Pathway Integrated Into Electronic Health Record
- Educational Outreach
- As-needed Follow Up
- Automatic Follow-up
Breakdown of trials Alan Schroeder, MD has run
Bronchiolitis
Soft Tissue Infections
Gastroenteritis
Urinary Tract Infection
Stomach Flu
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Alan Schroeder, MD specialize in?
Is Alan Schroeder, MD currently recruiting for clinical trials?
Are there any treatments that Alan Schroeder, MD has studied deeply?
What is the best way to schedule an appointment with Alan Schroeder, MD?
What is the office address of Alan Schroeder, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.